Cynthia Louise Flowers

CIK: 0001741455

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)2 (50.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

LSTA

LISATA THERAPEUTICS, INC.

Director

GTHX

G1 Therapeutics, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (4 total)

LSTA
LISATA THERAPEUTICS, INC.
Jan 9, 2026
Award(A)
Direct
30.5K shares-
LSTA
LISATA THERAPEUTICS, INC.
Jan 9, 2025
Award(A)
Direct
15.8K shares-
GTHX
G1 Therapeutics, Inc.
Sep 18, 2024
Disposition(D)
Direct
20K shares-
GTHX
G1 Therapeutics, Inc.
Sep 18, 2024
Tender Offer(U)
Direct
15.9K shares-

		Type	Shares	Price		Ownership
Jan 9, 2026	LSTA LISATA THERAPEUTICS, INC.	Award(A)	30,456	-	$0	Direct
Jan 9, 2025	LSTA LISATA THERAPEUTICS, INC.	Award(A)	15,789	-	$0	Direct
Sep 18, 2024	GTHX G1 Therapeutics, Inc.	Disposition(D)	20,000	-	$0	Direct
Sep 18, 2024	GTHX G1 Therapeutics, Inc.	Tender Offer(U)	15,889	-	$0	Direct

1-4 of 4 transactions

About Flowers Cynthia Louise

Flowers Cynthia Louise (SEC CIK 0001741455) files insider reports with the SEC as Director of LISATA THERAPEUTICS, INC. (LSTA) and Director of G1 Therapeutics, Inc. (GTHX).

Signal8 holds 3 ownership filings by Flowers Cynthia Louise, all Form 4s, filed between Sep 18, 2024 and Jan 13, 2026. Those filings report 4 transactions, from Sep 18, 2024 to Jan 9, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Flowers Cynthia Louise's filings is in BASKING RIDGE, NJ.

Recent filings by Flowers Cynthia Louise

Jan 9, 2026: Grant or award of LSTA shares (Form 4, code A).
Jan 9, 2025: Grant or award of LSTA shares (Form 4, code A).
Sep 18, 2024: Disposition to issuer transaction of GTHX shares (Form 4, code D).
Sep 18, 2024: Tender of shares transaction of GTHX shares (Form 4, code U).

Other insiders filing for LISATA THERAPEUTICS, INC. (LSTA)

Farrow Jeffrey S, Director
LOVE TED W, Director
Lehrer-Graiwer Joshua, President & COO
Mazzo David J, President & CEO
Nisco James, SVP, Fin/Treas, Chief Actg Off
Imam Tariq, SVP, Bus Dev, General Counsel

How to read Form 4 transaction codes